Diweddariad pwysig: newidiadau i geisiadau ar-lein  - Os nad ydych wedi dechrau neu gwblhau eich cais eto, adolygwch y wybodaeth sydd wedi'i diweddaru i osgoi unrhyw aflonyddwch os gwelwch yn dda. Darllen mwy

The content on this page is relevant to audiences outside Wales and is therefore available in English. For more information, please refer to our Welsh Language Policy or contact us [email protected].

MHA Tait Walker help Acculabs Diagnostics UK Ltd to secure NPIF – FW Capital & CBILS Loan

Keith Charlton
Keith Charlton
Wedi ei gyhoeddi:
Acculabs

We share relevant third party stories on our website. This release was written and issued by MHA Tait Walker.

Leading North East accountancy and advisory firm, MHA Tait Walker has helped Tees Valley-based Acculabs Diagnostics UK Ltd to secure a £325,000 CBILS backed loan from NPIF – FW Capital Debt Finance, managed by FW Capital and part of the Northern Powerhouse Investment Fund.  

The loan will be used to acquire equipment and working capital as well as help the business to continue to grow.

This is one of the first NPIF loans backed by CBILS to be secured through FW Capital who were recently announced as an accredited lender under the Government’s CBILS scheme.

Acculabs Diagnostics UK Ltd, based at Wynyard Business Park, is one of the UK’s leading private pathology organisations. It has been providing high quality pathology services to the private sector, the NHS and General Practitioners, and overseas clients for over 30 years. During that time, it has installed and managed over 120 laboratories in hospitals and clinics.

Steve Plaskitt, Partner for Corporate Finance at MHA Tait Walker, said: “We have worked with Acculabs for many years. It is a fantastic business which provides an invaluable service to the health care sector. The outbreak of COVID-19 has meant that some of their existing equipment will be used exclusively by the Government, and this has also presented opportunities to win new contracts to provide further COVID-19 testing. 

“We were able to create detailed financial forecasts which identified the potential funding gap which we shared with FW Capital. As a result, we were able to introduce a range of measures which will ensure the business can continue to flourish over the coming months.” 

The deal was facilitated by FW Capital investment executives Keith Charlton and Sam Streckert.  

Keith Charlton said: “The NPIF and CBILS backed funding we have provided to Acculabs enables them to continue to support the Government in the fight against COVID-19. Acculabs is a well-established business and our funding allows them to look to the future and build on this existing success.”

Chris Gordon, Chief Executive at Acculabs Diagnostic UK said: “We’re delighted to have secured the NPIF & CBILS funding and are hugely grateful to MHA Tait Walker and FW Capital for providing their expert support.  This injection of capital offsets any COVID-19 induced cashflow concerns and will allow us to continue our growth in 2020 and beyond.”

Grant Peggie, Director at British Business Bank said: “Following FW Capital’s accreditation as a CBILS lender, it’s fantastic to see this first NPIF – FW Capital & CBILS-backed investment get off the ground. In recent years we have seen strong levels of investment across the Northern Powerhouse region and we must ensure that following the pandemic this momentum is not lost. To this end, supporting growing regional businesses such as Acculabs Diagnostics will prove key.”